Sylvie Naar, PhD, Editor As 40% of premature deaths can be attributed to preventable behavioral factors, the single greatest opportunity to improve health lies in changing personal behavior such as…
PEDIATRIC CLINICS OF NORTH AMERICA www.pediatric.theclinics.com Consulting Editor BONITA F. STANTON June 2016 • Volume 63 • Number 3
Bonita F. Stanton, MD, Consulting Editor Since the appearance of Homo sapiens some 200,000 years ago, a primary challenge to mankind has been finding, acquiring, and consuming sufficient food sources…
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are clinically available personalized medicines approved for some individuals with cystic fibrosis (CF) to target the underlying defect of disease. This review summarizes…
Advances in the health care of individuals with cystic fibrosis have resulted in more than half of the population older than the age of 18 living longer, fuller lives. This…
Despite improvement in median life expectancy and overall health, some children with cystic fibrosis (CF) progress to end-stage lung or liver disease and become candidates for transplant. Transplants for children…
Cystic fibrosis is frequently complicated by endocrine disorders. Diabetes can be expected to affect most with CF and pancreatic insufficiency and varies widely in age of onset, but early identification…
Pulmonary disease is the primary cause of morbidity and mortality in people with cystic fibrosis (CF), but significant involvement within gastrointestinal, pancreatic, and hepatobiliary systems occurs as well. As in…
Close attention to nutrition and growth is essential in caring for children with cystic fibrosis (CF). Growth and nutritional status should be monitored as part of routine CF care. Children…
Respiratory system involvement in cystic fibrosis is the leading cause of morbidity and mortality. Defects in the cystic fibrosis transmembrane regulator (CFTR) gene throughout the sinopulmonary tract result in recurrent…
